Addressing growing public concerns over a recent surge in H1N1 cases across several states, Indian Council of Medical Research (ICMR) Director General Dr. Rajiv Bahl held a comprehensive press briefing to clarify the epidemiological landscape in India. He emphasized that the circulating virus is the familiar Influenza A (H1N1) pdm09 strain, the same lineage present since the 2009 pandemic, which has now transitioned into an endemic, seasonal flu.

Dr. Bahl stressed that minor genetic mutations occur naturally every flu season to help viruses stay active, but these changes do not signal a novel or more lethal strain. "There is absolutely no cause for panic," Dr. Bahl stated, noting that the overwhelming majority of cases remain mild and self-limiting. Highlighting India's robust sentinel surveillance system operating across 73 specialized hospitals, ICMR continuously monitors respiratory pathogens nationwide to track disease trajectory and clinical severity.

While the general public requires only standard hygiene and home care, medical authorities urge vulnerable demographics, including older adults, young children, pregnant women, and immunocompromised individuals, to remain cautious and consider WHO-recommended seasonal flu vaccinations.

Inside India's Respiratory Surveillance Architecture

India's real-time epidemiological tracking relies on a two-tiered laboratory surveillance mechanism managed by ICMR:

1. Sentinel Surveillance Network (73 Hospitals):

Specifically designated for routine, systematic viral mapping. Every week, each sentinel lab tests 25 samples collected from patients presenting with Severe Acute Respiratory Infection (SARI) (15 samples) and other influenza-like illness (ILI) syndromes (10 samples). This yields thousands of weekly tests, offering a clear baseline of circulating pathogens across all states.

2. Virus Research and Diagnostic Laboratories (VRDLs):

A broader network of 167 VRDLs established in government medical colleges processes diagnostic tests referred directly by clinicians.

Comprehensive Multiplex Viral Panels

Samples processed through the 73 sentinel surveillance sites undergo comprehensive multiplex testing covering a wide spectrum of respiratory viruses:

  • Influenza A: Dominant strains include common H1N1, while H3N2 currently accounts for 2-3% of circulating cases.
  • Influenza B: Victoria-lineage strains are active.
  • SARS-CoV-2: Showing a steady decline nationwide but coexisting with flu viruses.
  • Other Respiratory Viruses: Multiplex panels continuously screen for Human Metapneumovirus (hMPV), Adenovirus, and Parainfluenza viruses (types 1 through 4).

According to research published by the World Health Organization (WHO) and public health studies indexed on PubMed Central, integrated ILI and SARI surveillance provides essential early-warning detection for seasonal shifts and strain variations without requiring every individual mild case to be officially tallied.

Understanding H1N1: From Pandemic to Seasonal Flu

The Influenza A (H1N1) strain first caused a global pandemic in 2009. Over the past decade and a half, global health bodies, including the U.S. Centers for Disease Control and Prevention (CDC), have reclassified H1N1 as a regular seasonal influenza virus.

Flu viruses naturally undergo minor antigenic changes (drift) every year. These small structural shifts allow the virus to temporarily evade population immunity and cause predictable annual spikes. ICMR genomic sequencing confirms that current Indian isolates fall under the established H1N1 lineage (A/Missouri/11/2025-like clade) matching global patterns.

Clinical Management, Vulnerable Groups, and Antivirals

While most healthy individuals experience mild illness, fever, cough, sore throat, and body aches, certain vulnerable groups remain at higher risk for severe complications such as pneumonia:

  • Adults aged 65 and older
  • Children under 5 years of age
  • Pregnant women
  • Immunocompromised patients (such as individuals undergoing chemotherapy, organ transplant recipients, or those on long-term corticosteroids)

Treatment Protocols

  • Antivirals: Neuraminidase inhibitors like Oseltamivir (commonly known under the brand name Tamiflu) remain effective against circulating H1N1 strains. However, antivirals are reserved primarily for severe or high-risk cases under medical supervision.
  • Antibiotics: ICMR reiterates that antibiotics are ineffective against viral infections like H1N1 and should not be used indiscriminately.

Flu Vaccine Guidelines: Northern Hemisphere Formulation

The seasonal flu vaccine is not currently included in India's Universal Immunization Program (UIP), which focuses on childhood vaccines such as DPT and Polio. However, clinical guidance from ICMR and WHO supports selective vaccination:

  • High-Risk Individuals: Vulnerable groups seeking added protection should consult their healthcare provider regarding an annual flu shot.
  • Formulation: ICMR recommends using the Northern Hemisphere formulation, which aligns with currently circulating strains.
  • Pediatric Use: While not mandatory under the UIP, pediatricians are free to prescribe the flu vaccine for young children based on individual risk evaluations.

Precautionary Measures for Citizens

To prevent community transmission during seasonal peaks, ICMR recommends adopting respiratory hygiene practices similar to those used during COVID-19:

  • Rest at Home: Isolate and rest for 2 to 3 days upon experiencing flu symptoms.
  • Droplet Precautions: H1N1 spreads primarily via respiratory droplets. Maintain physical distance, avoid touching the face, and cover coughs or sneezes with a tissue or elbow.
  • Hand Hygiene: Wash hands frequently with soap and water or use an alcohol-based sanitizer.
  • Masking: While universal mask mandates are not required, wearing a mask in crowded indoor spaces protects vulnerable individuals.

Flu viruses follow a natural cycle: an initial peak, a plateau phase, and a subsequent decline. With multi-pathogen surveillance networks monitoring viral activity weekly, ICMR reassures the public that the current H1N1 increase reflects normal seasonal behaviour rather than a public health crisis. By following basic hygiene measures and protecting high-risk family members, communities can comfortably navigate the current flu season.



Disclaimer: This content including advice provides generic information only. It is in no way a substitute for a qualified medical opinion. Always consult a specialist or your own doctor for more information. NDTV does not claim responsibility for this information.